Dora Stölzl

405 total citations
10 papers, 187 citations indexed

About

Dora Stölzl is a scholar working on Dermatology, Immunology and Allergy and Immunology. According to data from OpenAlex, Dora Stölzl has authored 10 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 6 papers in Immunology and Allergy and 6 papers in Immunology. Recurrent topics in Dora Stölzl's work include Dermatology and Skin Diseases (10 papers), Allergic Rhinitis and Sensitization (5 papers) and IL-33, ST2, and ILC Pathways (4 papers). Dora Stölzl is often cited by papers focused on Dermatology and Skin Diseases (10 papers), Allergic Rhinitis and Sensitization (5 papers) and IL-33, ST2, and ILC Pathways (4 papers). Dora Stölzl collaborates with scholars based in Germany, Netherlands and Denmark. Dora Stölzl's co-authors include Stephan Weidinger, Jochen Schmitt, Elke Rodríguez, Inken Harder, Thomas Werfel, Annice Heratizadeh, Sascha Gerdes, Eva Haufe, Susanne Abraham and Lena Möbus and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology and British Journal of Dermatology.

In The Last Decade

Dora Stölzl

9 papers receiving 184 citations

Peers

Dora Stölzl

DERMA

IA

IMMUN

PHYSI

RHEUM

Melanie Hotze Germany

Tanda Murray United States

Anna Zaryczańska Poland

C. Mailhol France

R. Foelster‐Holst Germany

Jan Jekler Sweden

Sri Anusha Matta Singapore

Marie T. Vennegaard Denmark

Susanne Dugas‐Breit Germany

Eirini Nikolouli Germany

Melanie Hotze Germany

Dora Stölzl

257 ×1.6

DERMA

163 ×1.8

IA

60 ×0.9

IMMUN

117 ×2.4

PHYSI

36 ×1.1

RHEUM

Citations per year, relative to Dora Stölzl Dora Stölzl (= 1×) peers Melanie Hotze

Countries citing papers authored by Dora Stölzl

Since Specialization

Citations

This map shows the geographic impact of Dora Stölzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Stölzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Stölzl more than expected).

Fields of papers citing papers by Dora Stölzl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora Stölzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Stölzl. The network helps show where Dora Stölzl may publish in the future.

Co-authorship network of co-authors of Dora Stölzl

This figure shows the co-authorship network connecting the top 25 collaborators of Dora Stölzl. A scholar is included among the top collaborators of Dora Stölzl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora Stölzl. Dora Stölzl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Stölzl, Dora, Inken Harder, Elke Rodríguez, et al.. (2024). Stratum corneum and microbial biomarkers precede and characterize childhood atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 38(9). 1769–1775. 5 indexed citations

2.

Harder, Inken, Dora Stölzl, Matthias Hübenthal, et al.. (2024). Tralokinumab Treatment of Atopic Dermatitis Induces a Progressive Transcriptomic Response. Journal of Investigative Dermatology. 145(7). 1643–1652.e13. 2 indexed citations

3.

Stölzl, Dora, Lotte S. Spekhorst, Edward F. Knol, et al.. (2024). Type 2 Immune‐Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients. Clinical & Experimental Allergy. 55(1). 97–99.

4.

Stölzl, Dora, Inken Harder, Ivone Jakaša, et al.. (2024). Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitis. British Journal of Dermatology. 191(3). 344–350. 11 indexed citations

5.

Möbus, Lena, Elke Rodríguez, Inken Harder, et al.. (2022). Blood transcriptome profiling identifies 2 candidate endotypes of atopic dermatitis. Journal of Allergy and Clinical Immunology. 150(2). 385–395. 33 indexed citations

6.

Stölzl, Dora, Stephan Weidinger, & Katharina Drerup. (2021). A new era has begun: Treatment of atopic dermatitis with biologics. PubMed. 5(1). 265–273. 10 indexed citations

7.

Tollenaere, Maxim A. X., Thomas Litman, Elke Rodríguez, et al.. (2021). Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro. Acta Dermato Venereologica. 101(4). adv00447–adv00447. 19 indexed citations

8.

Möbus, Lena, Elke Rodríguez, Inken Harder, et al.. (2020). Atopic dermatitis displays stable and dynamic skin transcriptome signatures. Journal of Allergy and Clinical Immunology. 147(1). 213–223. 85 indexed citations

9.

Möbus, Lena, Elke Rodríguez, Inken Harder, et al.. (2020). Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitis. Journal of Allergy and Clinical Immunology. 147(5). 1959–1965.e2. 21 indexed citations

10.

Weidinger, Stephan, Dora Stölzl, Susanne Abraham, et al.. (2019). 127 TREATGermany registry: “real-world effectiveness” of dupilumab in atopic dermatitis. Journal of Investigative Dermatology. 139(9). S236–S236. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact